ACTAVIS INC $125.50

up +1.89


17/5/2013 05:17 PM  |  NYSE : ACT  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 125.50
Trade Time: May 17 5:09 PM Eastern Daylight Time
Change: 1.89 (1.53 %)
Prev Close: 123.61
Open: 123.37
Bid: 92.00
Ask: 0.00
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing ACT also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 12.3K +1.86%
BOMDF ALLIED HEALTHCARE GROUP 18.8K +1.27%
HRDND DC BRANDS INTERNATIONAL INC. N 2.6M +1.00%
TRAB THERABIOGEN 970.8K +1.00%
NRGXQ NEUROLOGIX 100.0K +0.82%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
3/15/2013 BUCHEN DAVID A Chief Legal Officer-Global&Sec -933 $91.59 -0.95%
3/15/2013 JOYCE R TODD CFO-Global & PAO -931 $91.59 -0.97%
3/14/2013 Mayr Charles M Chief Communic Off-Global -1,000 $91.77 -3.41%
3/12/2013 BUCHEN DAVID A Chief Legal Officer-Global&Sec 1,600 $38.92 1.63%
3/12/2013 BUCHEN DAVID A Chief Legal Officer-Global&Sec 6,400 $38.92 6.41%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ACT), click here.
View All

ACT Stock Analysis

  1. Teva Still Too Cheap, But Still Too Uncertain

    (TEVA,NVS,MYL,ACT )
    Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
Free Reports
  1.

    4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
  2.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  3.

    Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
Marketplace
Trading Center